Helicos Secures Bridge Loan, Abandons Plans for CLIA Lab as Cash Position Weakens, Revenues Fall
November 30, 2010
Helicos Secures Bridge Loan, Abandons Plans for CLIA Lab as Cash Position Weakens, Revenues Fall
With a cash position of $1.9 million as of Nov. 10, Helicos has reduced its headcount and has dropped plans to develop its own CLIA-certified genetic testing lab.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.